Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
R Soc Open Sci
2018 Jul 11;57:172182. doi: 10.1098/rsos.172182.
Show Gene links
Show Anatomy links
Synergistic effect of eicosapentaenoic acid-enriched phospholipids and sea cucumber saponin on orotic acid-induced non-alcoholic fatty liver disease in rats.
Guo Y
,
Han X
,
Che H
,
Li Z
,
Dong P
,
Xue C
,
Zhang T
,
Wang Y
.
???displayArticle.abstract???
Non-alcoholic fatty liver disease (NAFLD) is becoming an increasingly prevalent chronic liver disease all over the world. The present study was undertaken to explore the synergistic effects of sea cucumber saponins (SCS) and eicosapentaenoic acid-enriched phospholipids (EPA-PL) at ratios of 0.5 : 0.5 and 1 : 1 on NAFLD and demonstrate possible protective mechanisms. It was found that the combination of EPA-PL and SCS at half dose exhibited better effects than EPA-PL or SCS alone and the combination of EPA-PL and SCS at full dose in alleviating orotic acid (OA)-induced symptoms including growth parameters, serum parameters and liver function. Further evaluation of the mechanism illustrated that EPA-PL and SCS combination at the ratio of 0.5 : 0.5 could markedly reduce the mRNA expressions of fatty acid synthase, acetyl-CoA carboxylase, glucose-6-phosphate dehydrogenase and malic enzyme genes and significantly increase expression of genes relevant to fatty acid β-oxidation including peroxisome proliferator-activated receptor and its target genes (CPT1, CPT2 and ACOX1), suggesting that the protection of the EPA-PL and SCS combination at the ratio of 0.5 : 0.5 against OA-induced NAFLD might be mainly via lipogenesis inhibition and β-oxidation enhancement in the liver. The synergistic effects of EPA-PL and SCS make it possible to reduce the doses of EPA-PL or SCS to avoid side effects, which is of value for the development of dietary supplements or functional foods for preventing or treating NAFLD.
Figure 3. Synergistic effects of EPA-PL and SCS on hepatic mRNA expression involved in fatty acid biosynthesis in rats. The mRNA expression levels of SREBP-1c (a), FAS (b), ACC (c), G6PDH (d) and ME (e) were measured by RT-qPCR and results were normalized by GAPDH. Date are presented as mean ± s.e.m. (n = 7). *p < 0.05, **p < 0.01 compared to the Con group. Different letters indicate significant difference at p < 0.05 determined by ANOVA (Tukey's test).
Figure 4. Synergistic effects of EPA-PL and SCS on hepatic mRNA expression involved in fatty acid β-oxidation in rats. The mRNA expression levels of PPARα (a), CPT1 (b), CPT2 (c) and ACOX1 (d) were measured by RT-qPCR and results were normalized by GAPDH. Date are presented as mean ± s.e.m. (n = 7). *p < 0.05 compared to the Con group. Different letters indicate significant difference at p < 0.05 determined by ANOVA (Tukey's test).
Figure 5. The possible mechanisms involved in the synergistic effects of EPA-PL and SCS in OA-induced NAFLD rats.
Adams,
Treatment of non-alcoholic fatty liver disease.
2006, Pubmed
Adams,
Treatment of non-alcoholic fatty liver disease.
2006,
Pubmed
Ahmed,
Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).
2007,
Pubmed
BARTLETT,
Colorimetric assay methods for free and phosphorylated glyceric acids.
1959,
Pubmed
Buang,
Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid.
2005,
Pubmed
Chang,
Comparative Analysis of EPA/DHA-PL Forage and Liposomes in Orotic Acid-Induced Nonalcoholic Fatty Liver Rats and Their Related Mechanisms.
2018,
Pubmed
Chen,
Sea cucumber saponin liposomes ameliorate obesity-induced inflammation and insulin resistance in high-fat-diet-fed mice.
2018,
Pubmed
,
Echinobase
de Castro,
Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids.
2018,
Pubmed
Ding,
Comparative Study of EPA-enriched Phosphatidylcholine and EPA-enriched Phosphatidylserine on Lipid Metabolism in Mice.
2016,
Pubmed
Du,
Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population.
2008,
Pubmed
Franco,
Ratiometric drug delivery using non-liposomal nanocarriers as an approach to increase efficacy and safety of combination chemotherapy.
2017,
Pubmed
Gatch,
Discriminative and locomotor effects of five synthetic cathinones in rats and mice.
2015,
Pubmed
González,
Electronic paramagnetic resonance (EPR) for the study of ascorbyl radical and lipid radicals in marine organisms.
2013,
Pubmed
,
Echinobase
Han,
Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats.
2016,
Pubmed
Hu,
Dietary saponins of sea cucumber ameliorate obesity, hepatic steatosis, and glucose intolerance in high-fat diet-fed mice.
2012,
Pubmed
,
Echinobase
Hu,
Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling.
2010,
Pubmed
,
Echinobase
Kersten,
Integrated physiology and systems biology of PPARα.
2014,
Pubmed
Liao,
Intracellular antioxidant detoxifying effects of diosmetin on 2,2-azobis(2-amidinopropane) dihydrochloride (AAPH)-induced oxidative stress through inhibition of reactive oxygen species generation.
2014,
Pubmed
Liu,
Sea cucumber cerebrosides and long-chain bases from Acaudina molpadioides protect against high fat diet-induced metabolic disorders in mice.
2015,
Pubmed
,
Echinobase
Liu,
Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice.
2013,
Pubmed
Miyazawa,
Reduction of beta-oxidation capacity of rat liver mitochondria by feeding orotic acid.
1982,
Pubmed
Parra,
Impact of fish intake on oxidative stress when included into a moderate energy-restricted program to treat obesity.
2007,
Pubmed
Sanyal,
No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.
2014,
Pubmed
Scorletti,
Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.
2014,
Pubmed
Sher,
cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor.
1993,
Pubmed
Silchenko,
Structures and Biogenesis of Fallaxosides D₄, D₅, D₆ and D₇, Trisulfated Non-Holostane Triterpene Glycosides from the Sea Cucumber Cucumaria fallax.
2016,
Pubmed
,
Echinobase
Smith,
Non-alcoholic fatty liver disease.
2011,
Pubmed
Wang,
Study on possible mechanism of orotic acid-induced fatty liver in rats.
2011,
Pubmed
Wang,
Effects of two sulfated triterpene saponins echinoside A and holothurin A on the inhibition of dietary fat absorption and obesity reduction.
2014,
Pubmed
,
Echinobase
Ye,
Regulation of cholesterol and fatty acid synthesis.
2011,
Pubmed
Yoshii,
Autoxidation kinetic analysis of docosahexaenoic acid ethyl ester and docosahexaenoic triglyceride with oxygen sensor.
2002,
Pubmed
Yu,
Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review.
2016,
Pubmed
Yuan,
Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
2016,
Pubmed
Zhang,
Dietary sea cucumber cerebroside alleviates orotic acid-induced excess hepatic adipopexis in rats.
2012,
Pubmed
,
Echinobase
Zhang,
[Effect of sea cucumber cerebroside on lipid metabolism in fatty liver rats].
2010,
Pubmed
,
Echinobase
